FINANCIALS

XERS Xeris Biopharma Holdings Inc 1867096

Income Statement
Revenue	xers-20241231	203,070,000
Net Income	xers-20241231	-54,836,000
Profit Margin		-27%

Balance Sheet
Current Assets	167,662,000
Assets	323,060,000
Current Liabilities	100,443,000
Liabilities	352,675,000
Equity	-29,615,000
Shares Out	172,431,000

Cash Flow Statement
Operating Cash Flow	-36,981,000
Investing Cash Flow	4,883,000

Market Analysis
Market Cap	1,041,484,441
Price	6.04
BVPS	3.59
PB	1.51
PE	1881.62
PS	0.56
FCF	-32,098,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view XERS documents filed with the SEC.

XERS Filings Clear

View A List of Tickers